We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$26.7B
AUM Growth
+$3.85B
Cap. Flow
-$4.59B
Cap. Flow %
-17.17%
Top 10 Hldgs %
20.41%
Holding
1,231
New
232
Increased
271
Reduced
149
Closed
114
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
226
Kimberly-Clark
KMB
$37.5B
$15.6M 0.06%
109,313
+4,232
+4% +$570K
PAYX icon
227
Paychex
PAYX
$42.3B
$15.6M 0.06%
113,963
+4,412
+4% +$545K
CL icon
228
Colgate-Palmolive
CL
$74.2B
$15.5M 0.06%
181,949
+7,043
+4% +$550K
LOW icon
229
CALL
Lowe's Companies
LOW
$122B
$15.5M 0.06%
+59,800
New +$14.2M
ADSK icon
230
Autodesk
ADSK
$50.1B
$15.4M 0.06%
54,822
-4,320
-7% -$1.26M
AEP icon
231
American Electric Power
AEP
$72.4B
$15.2M 0.06%
171,338
+6,633
+4% +$560K
VMGAU
232
DELISTED
VMG Consumer Acquisition Corp. Unit
VMGAU
$15.2M 0.06%
+1,500,000
New +$15.1M
ONYXU
233
DELISTED
Onyx Acquisition Co. I Unit
ONYXU
$15.2M 0.06%
+1,500,000
New +$15.2M
AEAEU
234
DELISTED
AltEnergy Acquisition Corp Unit
AEAEU
$15.1M 0.06%
+1,500,000
New +$15.1M
IVCBU
235
DELISTED
Investcorp Europe Acquisition Corp I Unit
IVCBU
$15.1M 0.06%
+1,500,000
New +$15.1M
NFNT.U
236
DELISTED
Infinite Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
NFNT.U
$15.1M 0.06%
+1,500,000
New +$15.1M
CBRGU
237
DELISTED
Chain Bridge I Units
CBRGU
$15.1M 0.06%
+1,500,000
New +$15.1M
PSA icon
238
Public Storage
PSA
$61.7B
$15.1M 0.06%
40,302
+1,560
+4% +$521K
UTAAU
239
DELISTED
UTA Acquisition Corporation Units
UTAAU
$15.1M 0.06%
+1,500,000
New +$15M
SHCAU
240
DELISTED
Spindletop Health Acquisition Corp. Unit
SHCAU
$15.1M 0.06%
+1,500,000
New +$15.1M
DPCSU
241
DELISTED
DP Cap Acquisition Corp I Unit
DPCSU
$15.1M 0.06%
+1,500,000
New +$15.1M
LGVCU
242
DELISTED
LAMF Global Ventures Corp. I Unit
LGVCU
$15.1M 0.06%
+1,500,000
New +$15.1M
TRAQ.U
243
DELISTED
Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant
TRAQ.U
$15.1M 0.06%
+1,485,784
New +$15M
LGTOU
244
DELISTED
Legato Merger Corp. II Unit
LGTOU
$15M 0.06%
+1,500,000
New +$15.1M
CRECU
245
DELISTED
Crescera Capital Acquisition Corp Unit
CRECU
$15M 0.06%
+1,500,000
New +$15M
PACI.U
246
DELISTED
PROOF Acquisition Corp I Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
PACI.U
$15M 0.06%
+1,500,000
New +$15.1M
STET.U
247
DELISTED
ST Energy Transition I Ltd. SAIL securities, each consisting of one Class A ordinary share and one-half of one redeemable warrant
STET.U
$15M 0.06%
+1,500,000
New +$15M
NPABU
248
DELISTED
New Providence Acquisition Corp. II Unit
NPABU
$15M 0.06%
+1,500,000
New +$15.1M
BFAC.U
249
DELISTED
Battery Future Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
BFAC.U
$15M 0.06%
+1,500,000
New +$15M
DD icon
250
DuPont de Nemours
DD
$19B
$15M 0.06%
147,606
+5,715
+4% +$544K

Similar funds

Calamos Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Calamos Advisors held 1,231 positions worth $26.7B, up 17% from $22.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Calamos Advisors withdrew a net $4.59B in Q4 2021, closing 114 positions and reducing 149 holdings. Its most notable exit was AstraZeneca, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $169M.

  • Calamos Advisors's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 81,590 shares worth $169M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $151M increase.
  • Calamos Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $29.5M.
  • Calamos Advisors fully exited AstraZeneca in Q4 2021, selling an estimated $17.8M.
  • Calamos Advisors's ten largest holdings make up 20% of its $26.7B portfolio in Q4 2021.
  • Calamos Advisors opened 232 new positions and closed 114 in Q4 2021.
  • Calamos Advisors's portfolio value rose 17% quarter-over-quarter to $26.7B.

Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.